NCT01418222 2017-05-30FOLFOX/Bevacizumab With Onartuzumab (MetMAb) Versus Placebo as First-Line Treatment in Patients With Metastatic Colorectal CancerGenentech, Inc.Phase 2 Completed194 enrolled
NCT01590719 2016-08-09A Study of Onartuzumab (MetMAb) in Combination With mFOLFOX6 in Patients With Metastatic Human Epidermal Growth Factor Receptor 2 (HER2) Negative Gastroesophageal CancerHoffmann-La RochePhase 2 Completed123 enrolled